News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Kraig Biocraft Laboratories, Inc. Featured in Current Issue of Textile World


2/7/2012 9:13:22 AM

LANSING, MI--(Marketwire - February 07, 2012) - Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) (PINKSHEETS: KBLB) announces that the Company's spider silk technologies, including Monster Silk, are featured as the "Quality Fabric of the Month" in the current issue of the leading textile industry publication Textile World.

An electronic version of the Textile World article titled Spider Silk: Potential Unleashed, is available online at the following link, http://www.textileworld.com/Articles/2012/January/Jan-Feb_issue/Departments/QFOM_Spider_Silk.html

"We're honored to be featured in the current issue of Textile World as the 'Quality Fabric of the Month,'" stated Company CEO and founder, Kim Thompson. "This recognition of our achievements and our products by this leading industry publication just at the time when we are moving to commercialize our Monster Silk product could not have been more timely. I want to say thank you to the people at Textile World. For many executives in the textile industry this article will be their first glimpse of how our Company's scientific breakthroughs are making recombinant spider silk a viable, unique and exciting reality."

About Kraig Biocraft Laboratories, Inc.

Kraig Biocraft Laboratories, Inc. (www.KraigLabs.com) is a fully reporting biotechnology company that has achieved a series of scientific breakthroughs in spider silk production, with implications for the global textile industry.

Cautionary Statement Regarding Forward-Looking Information

Statements in this press release about the Company's future and expectations other than historical facts are "forward-looking statements." These statements are made on the basis of management's current views and assumptions. As a result, there can be no assurance that management's expectations will necessarily come to pass. These forward-looking statements generally can be identified by phrases such as "believes," "plans," "expects," "anticipates," "foresees," "estimated," "hopes," "develops," "researching," "research," "potential," "could" or other words or phrases of similar import. Similarly, statements in this release that describe the Company's business strategy, outlook, objectives, plans, intentions or goals should all be considered forward-looking statements. All such forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those in forward-looking statements. Management cautions that its ability to further its research, and create commercially-viable products may be affected by the competitive environment, the Company's financial condition and its ability to raise sufficient capital to meet the financial obligations of its business plan and to fund its continuing operations.

This press release does not constitute an offer to sell or the solicitation of an offer to buy any security and shall not constitute an offer, solicitation or sale of any securities in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of such jurisdiction.


Ben Hansel
Hansel Capital
Email Contact
(720) 288-8495


Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES